| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
BCL2 apoptosis regulator | 0.291 | 0.885 | 0.56 |
|
group | 0.100 | None | 1.000 | 43 | 0 | 1991 | 2019 | ||||||||
|
calcium sensing receptor | 0.410 | 0.846 | 4.7E-02 |
|
group | 0.100 | None | 0.977 | 43 | 0 | 2002 | 2020 | ||||||||
|
tripartite motif containing 13 | 0.462 | 0.846 | 0.64 |
|
group | 0.100 | None | 0.976 | 42 | 0 | 2015 | 2020 | ||||||||
|
arrestin 3 | 0.460 | 0.846 | 0.10 |
|
group | 0.100 | None | 0.976 | 42 | 0 | 2015 | 2020 | ||||||||
|
protein kinase cAMP-dependent type I regulatory subunit alpha | 0.401 | 0.846 | 1.00 |
|
group | 0.100 | None | 0.976 | 42 | 0 | 2015 | 2020 | ||||||||
|
CXADR Ig-like cell adhesion molecule | 0.454 | 0.885 | 0.37 |
|
group | 0.100 | None | 0.976 | 42 | 0 | 2015 | 2020 | ||||||||
|
SPG7 matrix AAA peptidase subunit, paraplegin | 0.436 | 0.885 | 2.0E-36 |
|
group | 0.100 | None | 0.976 | 42 | 0 | 2015 | 2020 | ||||||||
|
CXADR pseudogene 1 | 0.463 | 0.846 |
|
group | 0.100 | None | 0.976 | 42 | 0 | 2015 | 2020 | |||||||||
|
nuclear receptor subfamily 1 group I member 3 | 0.448 | 0.846 | 3.5E-08 |
|
group | 0.100 | None | 0.976 | 42 | 0 | 2015 | 2020 | ||||||||
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
group | 0.100 | None | 0.951 | 41 | 3 | 1993 | 2019 | ||||||||
|
CD19 molecule | 0.430 | 0.885 | 0.90 |
|
group | 0.100 | None | 1.000 | 39 | 0 | 2008 | 2019 | ||||||||
|
ETS variant transcription factor 6 | 0.477 | 0.731 | 0.97 |
|
group | 0.500 | None | 1.000 | 38 | 3 | 1995 | 2019 | ||||||||
|
Janus kinase 2 | 0.385 | 0.885 | 0.65 |
|
group | 0.500 | None | 0.969 | 32 | 1 | 2005 | 2019 | ||||||||
|
RUNX family transcription factor 1 | 0.425 | 0.808 | 0.65 |
|
group | 0.100 | None | 1.000 | 31 | 0 | 1998 | 2019 | ||||||||
|
ABL proto-oncogene 1, non-receptor tyrosine kinase | 0.432 | 0.923 | 1.00 |
|
group | 0.100 | None | 1.000 | 24 | 0 | 1993 | 2019 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta | 0.319 | 0.885 | 1.00 |
|
group | 0.100 | None | 1.000 | 24 | 0 | 2006 | 2019 | ||||||||
|
nucleoporin 98 and 96 precursor | 0.532 | 0.577 | 1.00 |
|
group | 0.100 | None | 0.952 | 21 | 0 | 2001 | 2019 | ||||||||
|
ATP binding cassette subfamily B member 1 | 0.344 | 0.885 | 1.3E-05 |
|
group | 0.400 | None | 1.000 | 20 | 0 | 1993 | 2019 | ||||||||
|
lysine methyltransferase 2A | 0.410 | 0.885 | 1.00 |
|
group | 0.100 | None | 1.000 | 18 | 0 | 1997 | 2019 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma | 0.320 | 0.885 | 1.4E-06 |
|
group | 0.100 | None | 1.000 | 17 | 0 | 2006 | 2020 | ||||||||
|
DNA methyltransferase 3 alpha | 0.445 | 0.846 | 7.4E-39 |
|
group | 0.100 | None | 1.000 | 15 | 0 | 2013 | 2018 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha | 0.292 | 0.923 | 1.00 |
|
group | 0.100 | None | 1.000 | 15 | 0 | 2006 | 2020 | ||||||||
|
cyclin dependent kinase inhibitor 2A | 0.300 | 0.885 | 0.39 |
|
group | 0.100 | None | 1.000 | 15 | 0 | 1995 | 2007 | ||||||||
|
BCR activator of RhoGEF and GTPase | 0.431 | 0.885 | 0.99 |
|
group | 0.100 | None | 1.000 | 15 | 0 | 1988 | 2018 | ||||||||
|
CD274 molecule | 0.324 | 0.923 | 1.9E-02 |
|
group | 0.100 | None | 1.000 | 15 | 0 | 2017 | 2020 |